ARCHIVES

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Seeking More Women, Minorities On Committees

November 9, 1979

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

Hopkins, Pennsylvania Ok’d As Comprehensive; No. Remains At 24

May 24, 1991

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989